Literature DB >> 19463846

Acute ischemic strokes due to bites by Daboia russelii in Sri Lanka - first authenticated case series.

I Gawarammana1, S Mendis, K Jeganathan.   

Abstract

UNLABELLED: Bites due to Russell's Viper (Daboia russelii) are common in Sri Lanka. Commonest haematological manifestation is consumptive coagulopathy and bleeding. Commonest neurological manifestations are ptosis, ophthalmoplegia and rarely respiratory failure which are due to presynaptic inhibition of neuromuscular transmission. There are no authenticated reports of acute ischemic strokes following bites by D. russelii. We report the first authenticated case series of ischemic strokes following bites by D. russelii in Sri Lanka.
METHODS: This was a prospective observational study of all atypical neurological manifestations following bites by D. russelii admitted to a hospital in Sri Lanka. We documented clinical features of all atypical neurological manifestations of D. russelii bites and recorded the findings of brain imaging.
RESULTS: During a period of 18 months, at one centre, 9 patients out of an estimated 500 victims of D. russelii bites were found to have Computerized Tomographic evidence of single or multiple ischemic (non-haemorrhagic) strokes of medium to large vessel territories of the brain. These patients had either low Glasgow coma scale or hemiparesis within minutes to 4 days following bites. One patient died and another had gross neurological deficit, while others had mild or no neurological deficit at three months. DISCUSSION: This report confirms that ischemic strokes can occur following envenoming by D. russelii. Involvement of multiple medium to large vessel territories and absence of watershed infarctions points to prothrombotic properties of the venom as the putative mechanism.

Entities:  

Mesh:

Year:  2009        PMID: 19463846     DOI: 10.1016/j.toxicon.2009.05.006

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  16 in total

Review 1.  Stroke in South Asian countries.

Authors:  Mohammad Wasay; Ismail A Khatri; Subhash Kaul
Journal:  Nat Rev Neurol       Date:  2014-02-11       Impact factor: 42.937

2.  Acute ischemic stroke following Hump-nosed viper envenoming; first authenticated case.

Authors:  Vijayabala Jeevagan; Thashi Chang; Christeine Ariaranee Gnanathasan
Journal:  Thromb J       Date:  2012-09-20

Review 3.  Cerebrovascular disease in South Asia - Part II: Risk factors and prevention.

Authors:  Deepti Vibha; Kameshwar Prasad
Journal:  JRSM Cardiovasc Dis       Date:  2012-11-30

4.  Acute myocardial infarction following a possible direct intravenous bite of Russell's viper (Daboia russelli).

Authors:  Anjana Silva; Senaka Pilapitiya; Sisira Siribaddana
Journal:  BMC Res Notes       Date:  2012-09-12

5.  Commentary.

Authors:  Subramanian Senthilkumaran; Namasivayam Balamurugan; Ponniah Thirumalaikolundusubramanian
Journal:  J Neurosci Rural Pract       Date:  2012-01

6.  Chronic Musculoskeletal Disabilities following Snake Envenoming in Sri Lanka: A Population-Based Study.

Authors:  Subashini Jayawardana; Ariaranee Gnanathasan; Carukshi Arambepola; Thashi Chang
Journal:  PLoS Negl Trop Dis       Date:  2016-11-04

7.  Aspirin plus tirofiban inhibit the thrombosis induced by Russell's viper venom.

Authors:  Ren-Chieh Wu; Ping-Tse Chou; Li-Kuang Chen
Journal:  Thromb J       Date:  2016-10-04

Review 8.  Antivenom for Neuromuscular Paralysis Resulting From Snake Envenoming.

Authors:  Anjana Silva; Wayne C Hodgson; Geoffrey K Isbister
Journal:  Toxins (Basel)       Date:  2017-04-19       Impact factor: 4.546

9.  Bilateral blindness following Russell's viper bite - a rare clinical presentation: a case report.

Authors:  Chandrika Jayakanthi Subasinghe; Chamara Sarathchandra; Thambyaiah Kandeepan; Aruna Kulatunga
Journal:  J Med Case Rep       Date:  2014-03-24

10.  Case report: acute demyelinating encephalomyelitis following viper bite.

Authors:  Anyi Xu; Renfei Shan; Daochao Huang; Jiajia Zhou; Anaswasseem Keenoo; Jie Qin
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.